These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17150246)

  • 1. The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma.
    Mylona E; Alexandrou P; Giannopoulou I; Liapis G; Sofia M; Keramopoulos A; Nakopoulou L
    Gynecol Oncol; 2007 Mar; 104(3):557-63. PubMed ID: 17150246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.
    Mylona E; Alexandrou P; Mpakali A; Giannopoulou I; Liapis G; Markaki S; Keramopoulos A; Nakopoulou L
    Eur J Surg Oncol; 2007 Apr; 33(3):294-300. PubMed ID: 17129704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
    Nishida N; Yano H; Komai K; Nishida T; Kamura T; Kojiro M
    Cancer; 2004 Sep; 101(6):1364-74. PubMed ID: 15368324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness.
    Dhakal HP; Naume B; Synnestvedt M; Borgen E; Kaaresen R; Schlichting E; Wiedswang G; Bassarova A; Holm R; Giercksky KE; Nesland JM
    Histopathology; 2012 Sep; 61(3):350-64. PubMed ID: 22690749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma.
    Meunier-Carpentier S; Dales JP; Djemli A; Garcia S; Bonnier P; Andrac-Meyer L; Lavaut MN; Allasia C; Charpin C
    Int J Oncol; 2005 Apr; 26(4):977-84. PubMed ID: 15753992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma].
    Dales JP; Garcia S; Bonnier P; Duffaud F; Carpentier S; Djemli A; Ramuz O; Andrac L; Lavaut M; Allasia C; Charpin C
    Ann Pathol; 2003 Sep; 23(4):297-305. PubMed ID: 14597894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of VEGFR-1 (Flt-1) in breast cancer is associated with VEGF expression and with node-negative tumour stage.
    Schmidt M; Voelker HU; Kapp M; Dietl J; Kammerer U
    Anticancer Res; 2008; 28(3A):1719-24. PubMed ID: 18630531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
    Jüttner S; Wissmann C; Jöns T; Vieth M; Hertel J; Gretschel S; Schlag PM; Kemmner W; Höcker M
    J Clin Oncol; 2006 Jan; 24(2):228-40. PubMed ID: 16344322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Feb; 9(2):716-21. PubMed ID: 12576440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
    Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N
    Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Tsukiyama A; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Mod Pathol; 2003 Apr; 16(4):309-14. PubMed ID: 12692195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma.
    Yokoyama Y; Charnock-Jones DS; Licence D; Yanaihara A; Hastings JM; Holland CM; Emoto M; Sakamoto A; Sakamoto T; Maruyama H; Sato S; Mizunuma H; Smith SK
    Clin Cancer Res; 2003 Apr; 9(4):1361-9. PubMed ID: 12684405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
    Brychtova S; Bezdekova M; Brychta T; Tichy M
    Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
    Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma.
    Yang W; Klos K; Yang Y; Smith TL; Shi D; Yu D
    Cancer; 2002 Jun; 94(11):2855-61. PubMed ID: 12115372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of angiogenesis-related factors in invasive breast cancer and its clinical significance].
    Wang XB; Yang QX; Pei XJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):860-3. PubMed ID: 16793622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma.
    MacConmara M; O'Hanlon DM; Kiely MJ; Connolly Y; Jeffers M; Keane FB
    Int J Oncol; 2002 Apr; 20(4):717-21. PubMed ID: 11894115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
    Donnem T; Al-Saad S; Al-Shibli K; Delghandi MP; Persson M; Nilsen MN; Busund LT; Bremnes RM
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6649-57. PubMed ID: 18006765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
    Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
    Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.